HeartGenetics

Executive Summary

HeartGenetics is a Portuguese digital health company founded in 2010 that operates as a licensed medical genetics laboratory. The company specializes in adding intelligence to genetic data, offering personalized genetic testing and analysis in wellness, cardiovascular disease, and pharmacogenomics. Its core mission is to leverage genetic insights for preventive health and personalized treatment plans. With a focus on actionable genomic interpretation, HeartGenetics aims to bridge the gap between raw genetic data and clinical utility, empowering individuals and healthcare providers to make informed decisions. The company’s platform integrates proprietary algorithms and clinical guidelines to deliver clear, personalized reports. As a private company based in Lisbon, HeartGenetics operates in the growing diagnostics and genomics space, though specific financial details and stage are not disclosed.

Upcoming Catalysts (preview)

• Q2 2027Expansion of pharmacogenomics testing into new European markets70% success
• Q4 2026Regulatory approval for a novel cardiovascular genetic panel60% success
• Q3 2026Strategic partnership with a major healthcare provider55% success